Worldwide Next-Generation Sequencing Industry to 2025 - Key Drivers and Trends prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
/Artificial Intelligence In Medical Imaging Market Potential Growth, Share, Demand And Analysis Of Key Players- Research Forecasts To 2027 | DBMR
Artificial Intelligence In Medical Imaging Market Potential Growth, Share, Demand And Analysis Of Key Players- Research Forecasts To 2027 | DBMR
Artificial Intelligence In Medical Imaging Market research report conducts study on production capacity, consumption, import, and export for all major regions across the globe. The report is a professional in-depth study on the current state of the market. Analysis and discussion of important industry trends, market size, and market share estimates are revealed in the report. The market report also contains the drivers and restraints for this market that are derived from SWOT analysis, and also shows all the recent developments, product launches, joint ventures, mergers, and acquisitions by the several key players and brands that are driving the market by systemic company profiles.
Can biotech change its DNA? Racial equity remains a missing ingredient in the industry bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted).
Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising for the following liquid biopsy applications: noninvasive prenatal screening for average-risk populations; cancer screening and early detection; and recurrence monitoring for cancer patients.
Biomarker types of most interest include cell-free DNA (cfDNA), circulating tumor cells (CTCs) and exosomes. Ongoing advances in sensitive molecular technologies such as next-generation DNA sequencing (NGS) and digital polymerase chain reaction (dPCR) enable the detection of biomarkers that are present